Abstract
Chronic restrictive lung disease in a 9-year-old boy with dyskeratosis congenita (DC) 7 years after allogeneic bone marrow transplantation (BMT) is described. When he was 1 year and 10 months old, severe aplastic anemia developed. He received a marrow transplant from his HLA serologically identical, but HLA-DP mismatched brother. He developed grade II acute graft-versus-host disease (GVHD) and thereafter chronic GVHD of progressive type, and was treated with both prednisolone and azathioprine resulting in clinical improvement. Thereafter he complained of dyspnea, and bilateral noncircumscribed interstitial shadows on chest CT scan were present. His pulmonary function showed restrictive changes. Prednisolone was not effective and he died of respiratory failure. Post-mortem examination confirmed interstitial fibrosis, lymphocytic infiltration of the bronchioles and alveoli with luminal fibrosis. There was no evidence of chronic GVHD in the skin and the liver. These findings raise the possibility that this pulmonary complication was associated with DC itself.
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yabe, M., Yabe, H., Hattori, K. et al. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation. Bone Marrow Transplant 19, 389–392 (1997). https://doi.org/10.1038/sj.bmt.1700674
Received:
Accepted:
Issue Date:
Keywords
- dyskeratosis congenita
- allogeneic bone marrow transplantation
- chronic GVHD
- restrictive lung disease
Further reading
-
Diverse Pathological Findings of Interstitial Lung Disease in a Patient with Dyskeratosis Congenita
Internal Medicine (2021)
-
Dyskeratosis congenita: a literature review
JDDG: Journal der Deutschen Dermatologischen Gesellschaft (2020)
-
Dyskeratosis congenita: ein Literaturüberblick
JDDG: Journal der Deutschen Dermatologischen Gesellschaft (2020)
-
Diagnostic utility of telomere length testing in a hospital-based setting
Proceedings of the National Academy of Sciences (2018)
-
Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita
Hematology/Oncology Clinics of North America (2018)